A study in the October issue of <i>Gastroenterology</i> evaluated the prevalence of celiac disease (CD) antibodies and biopsy-confirmed CD among patients with nonconstipated irritable bowel syndrome (NC-IBS) in a large US population. Dr. Kuemmerle speaks with author Dr. Brooks D. Cash of the National Naval Medical Center, Bethesda, Maryland. Plus, a rundown of top stories from this month's issue of <i>GI and Hepatology News</i>